The global contraceptives market is set to gain traction from the increasing adoption of low-dose combined oral contraceptives (COCs). They include progestogen blended with 20-35 micrograms of ethinylestradiol. This information is given by Fortune Business Insights™ in a new report, titled, “Contraceptives Market Size, Share & COVID-19 Impact Analysis, By Product (Contraceptive Drugs and Contraceptive Devices), By Gender (Male & Female) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Channel, Clinics, Public Channel & NGOs, and Others), and Regional Forecast, 2020-2027.” The report further states that the market size was USD 22.49 billion in 2019 and is projected to reach USD 30.15 billion by 2027, exhibiting a CAGR of 5.5% during the forecast period.

The U.N. Population Fund (UNFPA) mentioned that in the coming months, 7 million unintended pregnancies are set to occur. Also, approximately 47 million women belonging to low- and medium-income countries would be unable to use unique contraceptives owing to the emergence of the COVID-19 pandemic. Besides, a major decline in the supply and manufacturing of these products worldwide would affect growth negatively. We are delivering in-depth research reports to help you better understand the current scenario of the market.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contraceptives-market-100064

Fortune Business Insights™ lists out the names of all the renowned producers present in the market. They are as follows:

• Pfizer, Inc.
• Bayer AG
• Cooper Surgical, Inc.
• The Female Health Company
• Teva Pharmaceutical Industries Limited
• Merck & Co., Inc.
• Mayer Laboratories, Inc
• Church & Dwight, Co., Inc.
• Medisafe Distribution Inc.
• Other Players

As the population is surging worldwide, the governments are taking persistent initiatives to conduct awareness campaigns for lowering the risks of unwanted pregnancies, sexual disorders, and abortion. The Government of India, for instance, committed to deliver family planning services by the end of 2020 to 48 million new users at the London Summit on Family Planning. Similarly, the U.S. government developed an infant and a maternal health initiative to promote the usage of contraceptives effectively. However, contraceptives may cause multiple side-effects, such as migraine, headaches, and nausea. This factor may hinder contraceptives market growth.

About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:
Fortune Business Insights Pvt. Ltd. 9th Floor, Icon Tower, Baner - Mahalunge Road, Baner, Pune-411045, Maharashtra, India. Phone: US :+1 424 253 0390 UK : +44 2071 939123 APAC : +91 744 740 1245 Email: mailto:[email protected]